These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 25282183

  • 21. Simultaneous administration of recombinant tissue plasminogen activator and edaravone in acute cerebral ischemic stroke patients.
    Takenaka K, Kato M, Yamauti K, Hayashi K.
    J Stroke Cerebrovasc Dis; 2014; 23(10):2748-2752. PubMed ID: 25307430
    [Abstract] [Full Text] [Related]

  • 22. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N, Tasneem N, Shaban A, Dandapat S, Ahmed U, Policeni B, Olalde H, Shim H, Samaniego EA, Pieper C, Ortega-Gutierrez S, Leira EC, Adams HP.
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
    [Abstract] [Full Text] [Related]

  • 23. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE, Monlezun DJ, Siegler JE, Waring ED, Dowell LN, Samai AA, George AJ, Kimbrough T, Berthaud J, Martin-Schild S.
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [Abstract] [Full Text] [Related]

  • 24. Administration of free radical scavenger edaravone associated with higher frequency of hemorrhagic transformation in patients with cardiogenic embolism.
    Mishina M, Komaba Y, Kobayashi S, Kominami S, Fukuchi T, Mizunari T, Teramoto A, Katayama Y.
    Neurol Med Chir (Tokyo); 2008 Jul; 48(7):292-7. PubMed ID: 18654047
    [Abstract] [Full Text] [Related]

  • 25. Effect of blood pressure on early neurological deterioration of acute ischemic stroke patients with intravenous rt-PA thrombolysis may be mediated through oxidative stress induced blood-brain barrier disruption and AQP4 upregulation.
    He Y, Yang Q, Liu H, Jiang L, Liu Q, Lian W, Huang J.
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104997. PubMed ID: 32689627
    [Abstract] [Full Text] [Related]

  • 26. Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.
    Simão F, Ustunkaya T, Clermont AC, Feener EP.
    Blood; 2017 Apr 20; 129(16):2280-2290. PubMed ID: 28130211
    [Abstract] [Full Text] [Related]

  • 27. The Impact of Discrepancy between Measured versus Stated Weight on Hemorrhagic Transformation and Clinical Outcomes after Intravenous Alteplase Thrombolysis.
    Shin DH, Kang MJ, Kim JW, Shin DJ, Park HM, Sung YH, Kim EY.
    Cerebrovasc Dis; 2017 Apr 20; 44(5-6):241-247. PubMed ID: 28848080
    [Abstract] [Full Text] [Related]

  • 28. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G, Fang J, Kapral MK, Tu JV, Mamdani M, Austin P, Johnston SC, Investigators of the Registry of the Canadian Stroke Network (RCSN), Stroke Outcomes Research Canada (SORCan) Working Group.
    Stroke; 2012 May 20; 43(5):1315-22. PubMed ID: 22308252
    [Abstract] [Full Text] [Related]

  • 29. Neutrophil-to-Lymphocyte Ratio and Response to Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.
    Pektezel MY, Yilmaz E, Arsava EM, Topcuoglu MA.
    J Stroke Cerebrovasc Dis; 2019 Jul 20; 28(7):1853-1859. PubMed ID: 31072698
    [Abstract] [Full Text] [Related]

  • 30. Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain.
    Yamashita T, Kamiya T, Deguchi K, Inaba T, Zhang H, Shang J, Miyazaki K, Ohtsuka A, Katayama Y, Abe K.
    J Cereb Blood Flow Metab; 2009 Apr 20; 29(4):715-25. PubMed ID: 19142198
    [Abstract] [Full Text] [Related]

  • 31. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
    Ishiguro M, Kawasaki K, Suzuki Y, Ishizuka F, Mishiro K, Egashira Y, Ikegaki I, Tsuruma K, Shimazawa M, Yoshimura S, Iwama T, Hara H.
    Neuroscience; 2012 Sep 18; 220():302-12. PubMed ID: 22710066
    [Abstract] [Full Text] [Related]

  • 32. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M, Furie KL, Koroshetz WJ, Lee H, Barron M, Lederer M, Wang X, Zhu M, Sorensen AG, Lo EH, Kelly PJ.
    Neurology; 2006 May 23; 66(10):1550-5. PubMed ID: 16717217
    [Abstract] [Full Text] [Related]

  • 33. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.
    Wada T, Yasunaga H, Inokuchi R, Horiguchi H, Fushimi K, Matsubara T, Nakajima S, Yahagi N.
    J Neurol Sci; 2014 Oct 15; 345(1-2):106-11. PubMed ID: 25085762
    [Abstract] [Full Text] [Related]

  • 34. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A, Memon A, Razavi SM, Lail NS, Vaughn CB, Mohammadi P, Sawyer RN, Shirani P.
    J Stroke Cerebrovasc Dis; 2021 May 15; 30(5):105678. PubMed ID: 33640783
    [Abstract] [Full Text] [Related]

  • 35. Derivation and Validation of a Scoring System for Intravenous Tissue Plasminogen Activator Use in Asian Patients.
    Yeo LLL, Chien SC, Lin JR, Liow CW, Lee JD, Peng TI, Luen TH, Sharma V, Chan B, Lee TH, SRICHS Group.
    J Stroke Cerebrovasc Dis; 2017 Aug 15; 26(8):1695-1703. PubMed ID: 28408066
    [Abstract] [Full Text] [Related]

  • 36. Predictive role of admission serum glucose, baseline NIHSS score, and fibrinogen on hemorrhagic transformation after intravenous thrombolysis with alteplase in acute ischemic stroke.
    Huang P, Yi XY.
    Eur Rev Med Pharmacol Sci; 2023 Oct 15; 27(20):9710-9720. PubMed ID: 37916334
    [Abstract] [Full Text] [Related]

  • 37. Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke.
    Lee VH, Conners JJ, Cutting S, Song SY, Bernstein RA, Prabhakaran S.
    J Stroke Cerebrovasc Dis; 2014 Sep 15; 23(8):2139-2144. PubMed ID: 25081309
    [Abstract] [Full Text] [Related]

  • 38. YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy).
    Aoki J, Kimura K, Morita N, Harada M, Metoki N, Tateishi Y, Todo K, Yamagami H, Hayashi K, Terasawa Y, Fujita K, Yamamoto N, Deguchi I, Tanahashi N, Inoue T, Iwanaga T, Kaneko N, Mitsumura H, Iguchi Y, Ueno Y, Kuramoto Y, Ogata T, Fujimoto S, Yokoyama M, Nagahiro S, YAMATO Study Investigators.
    Stroke; 2017 Mar 15; 48(3):712-719. PubMed ID: 28119434
    [Abstract] [Full Text] [Related]

  • 39. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):543-9. PubMed ID: 24046398
    [Abstract] [Full Text] [Related]

  • 40. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.
    Murray NM, Ke M, Yee A, Chen C, Wong C, Bedenk A, Fernandes J, Barazangi N, Tong D.
    J Stroke Cerebrovasc Dis; 2019 Sep 01; 28(9):2488-2495. PubMed ID: 31277995
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.